Jeff Yass’s Nautilus Biotechnolgy NAUT Stock Holding History

Jeff Yass’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,200	Closed	-$191K	–	14146
2026 Q1	$191K	Buy	+49,200	New	+$121K	﹤0.01%	11757
2023 Q4	–	Sell	-12,000	Closed	-$37.9K	–	12964
2023 Q3	$37.9K	Buy	+12,000	New	+$39.1K	﹤0.01%	11407
2022 Q2	–	Sell	-15,300	Closed	-$66K	–	13578
2022 Q1	$66K	Sell	15,300 -9,900	-39%	-$40.6K	﹤0.01%	12165
2021 Q4	$131K	Buy	+25,200	New	+$135K	﹤0.01%	11944
2021 Q2	–	Sell	-17,800	Closed	-$245K	–	13016
2021 Q1	$245K	Buy	+17,800	New	+$247K	﹤0.01%	11032

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Jeff Yass's NAUT Position: Q2 2026 in Review

Jeff Yass opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 890,949 shares worth $1.67M. The stake represents ﹤0.01% of the portfolio and ranks #6903 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NAUT as recently as Q4 2025.

Jeff Yass first reported a position in NAUT in Q2 2021 and has held it in 15 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Jeff Yass held 890,949 shares of Nautilus Biotechnolgy worth $1.67M as of Q2 2026.
Nautilus Biotechnolgy was a new Jeff Yass position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6903 holding.
Jeff Yass first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 15 quarters since.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.